Ablative Solutions

Ablative Solutions, Inc is pioneering new approaches for the treatment of hypertension.

[Ablative Solutions @AblatvSolutions]

We are just an hour away from Professor Horst Sievert’s live presentation on Renal Denervation with Alcohol. This is a presentation you will not want to miss. #TCTConnect #hypertension #interventionalcardiology #highbloodpressure
https://t.co/VdFTNDHG5H

[Ablative Solutions @AblatvSolutions]

We invite you to join Prof. Horst Sievert’s Featured Live Case Presentation at TCT on Thurs, Oct 15th at 12:40 EST: Renal Denervation with Alcohol (Peregrine System Kit). #TCT2020 #TCTConnect #hypertension #interventionalcardiology #highbloodpressure
https://t.co/1jPCzj6bPv

[Ablative Solutions @AblatvSolutions]

First Patient Enrolled and Randomized in Global #ClinicalTrial Evaluating Ablative Solution’s Novel Therapy for Uncontrolled #Hypertension -
TARGET BP Clinical Program studies #renaldenervation using the investigational Peregrine System Kit https://t.co/Zvxg9zyCVu

[Ablative Solutions @AblatvSolutions]

Ablative Solutions is pleased to announce that Kate Rumrill has joined the company as President and CEO. https://t.co/dkR8NEO0lX

[Ablative Solutions @AblatvSolutions]

Prof. Horst Sievert presented Peregrine Post-Market study results for the CE-marked Peregrine Catheter at #CRT2019 on behalf of European investigators. https://t.co/XoxH0RBGtY

[Ablative Solutions @AblatvSolutions]

Strong commitment for TARGET BP clinical program to help address uncontrolled hypertension. https://t.co/ySwHUPgAYd

[Nicole Osmer @nicoleosmer]

Congrats to Ablative Solutions on $77 million raise to support its global clinical program for new #renaldenervation #hypertension treatment https://t.co/TCT5HFOeoI

[Nicole Osmer @nicoleosmer]

Congratulations to Dr. Tim Fischell for being inducted as a Fellow of the National Academy of Inventors! #NAI2018 @AblatvSolutions #medtech #innovation

[Ablative Solutions @AblatvSolutions]

Felix Mahfoud shares Peregrine Post-Market Study results at #CRT2018 and announces plans for TARGET BP OFF-MED Clinical Trial.

[Ablative Solutions @AblatvSolutions]

FDA Allows @AblatvSolutions to Initiate Phase 2 TARGET-BP I Trial of
Combo Drug/Device Tx for Hypertension under IND
https://t.co/VqWolfaH74

[Ablative Solutions @AblatvSolutions]

Congratulations to Robert Fischell on Medal of Tech & Innovation from @POTUS! https://t.co/9bJEGzI7HF

[National Academy of Inventors @AcadofInventors]

Congrats #NAI Fellow Robert Fischell @UofMaryland received @NSTMF Medal of Tech & Innovation from @POTUS today!

[Ablative Solutions @AblatvSolutions]

Transcath perivasc. alcohol denervation addresses technical challenges of energy-based #renaldenervation #EuroPCR

[Ablative Solutions @AblatvSolutions]

Looking forward to Stefan Bertog's presentation Wed AM #EuroPCR #hypertension https://t.co/6P4ymkmQXs

[Ablative Solutions @AblatvSolutions]

@WWojakowski presents on clinical experience with Peregrine #EuroPCR @PCRonline